{"transactions":[{"id":873493,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-02T21:30:11.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 26, 2027, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":65000,"derivative":{"exercise_price":1.65,"expiration_date":"2036-02-25","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001654055-26-000002","document":"form4-03022026_040307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000165405526000002/form4-03022026_040307.xml","form_type":"4"}},{"id":1105946,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-18T20:45:05.000Z","date":"2025-02-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 20, 2026, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":0.57,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001415889-25-017695","document":"form4-06182025_040601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000141588925017695/form4-06182025_040601.xml","form_type":"4"}},{"id":1330465,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:15:15.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in 36 equal monthly installments, subject to the Reporting Person's continued services through such date."}],"balance_after":90000,"derivative":{"exercise_price":1.06,"expiration_date":"2034-12-11","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-24-029471","document":"form4-12162024_041211.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000141588924029471/form4-12162024_041211.xml","form_type":"4"}},{"id":1618584,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-26T22:53:07.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 22, 2025, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.68,"expiration_date":"2034-02-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-24-003956","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919124003956/doc4.xml","form_type":"4"}},{"id":1989608,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-27T21:44:55.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 23, 2024 subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.5,"expiration_date":"2033-02-22","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-013203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919123013203/doc4.xml","form_type":"4"}},{"id":2002813,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-21T16:31:55.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 16, 2022, the reporting person was granted 8,750 RSUs, which vested in full on February 16, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by The Karen Bernstein Trust, As Amended & Restated, of which the reporting person is a trustee."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0000899243-23-005693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654055/000089924323005693/doc4.xml","form_type":"4"}},{"id":2002812,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-21T16:31:55.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":8750,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held by The Karen Bernstein Trust, As Amended & Restated, of which the reporting person is a trustee."}],"balance_after":8750,"source":{"system":"sec-edgar","filing":"0000899243-23-005693","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654055/000089924323005693/doc4.xml","form_type":"4"}},{"id":2224869,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-21T16:48:27.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 17, 2022, David Flores and Karen Bernstein Trust Agreement was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 17, 2022, David Flores and Karen Bernstein Trust Agreement was granted 1,500 restricted stock units, which shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reporting person is a trustee of David Flores and Karen Bernstein Trust Agreement."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0000899243-22-023403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654055/000089924322023403/doc4.xml","form_type":"4"}},{"id":2224868,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-21T16:48:27.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier to occur of (i) June 17, 2023 and (ii) the Issuer's next annual meeting of stockholders."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reporting person is a trustee of David Flores and Karen Bernstein Trust Agreement."}],"balance_after":7500,"derivative":{"exercise_price":2.83,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-22-023403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654055/000089924322023403/doc4.xml","form_type":"4"}},{"id":2298180,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-12T20:44:23.000Z","date":"2022-04-08","kind":"grant","acquired":true,"shares":69424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable October 8, 2022 and the remaining shares will vest in 18 equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":69424,"derivative":{"exercise_price":3.22,"expiration_date":"2032-04-07","underlying":"Common Stock","underlying_shares":69424},"source":{"system":"sec-edgar","filing":"0001209191-22-024159","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919122024159/doc4.xml","form_type":"4"}},{"id":2384719,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-18T16:06:13.000Z","date":"2022-02-16","kind":"grant","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 16, 2022, David Flores and Karen Bernstein Trust Agreement was granted 8,750 restricted stock units, which vest on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 16, 2022, David Flores and Karen Bernstein Trust Agreement was granted 8,750 restricted stock units, which vest on the first anniversary of the grant date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person is a trustee of David Flores and Karen Bernstein Trust Agreement."}],"balance_after":8750,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0000899243-22-007016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654055/000089924322007016/doc4.xml","form_type":"4"}},{"id":2411323,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-05T01:47:33.000Z","date":"2022-02-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on February 3, 2023 subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":2.72,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-007325","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919122007325/doc4.xml","form_type":"4"}},{"id":2658221,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T19:17:00.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier to occur of (i) June 18, 2022, or (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":10000,"derivative":{"exercise_price":24.13,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-21-025399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654055/000089924321025399/doc4.xml","form_type":"4"}},{"id":2671294,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-12T00:15:06.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 11, 2022 subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":4.49,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-040069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919121040069/doc4.xml","form_type":"4"}},{"id":2707140,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-19T00:51:36.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":1750,"derivative":{"exercise_price":3.67,"expiration_date":"2031-05-16","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001209191-21-033825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919121033825/doc4.xml","form_type":"4"}},{"id":3006003,"issuer":{"id":114958,"kind":"organization","name":"Codiak BioSciences, Inc.","symbol":"CDAK"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-15T20:14:34.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier to occur of (i) October 13, 2021, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":10000,"derivative":{"exercise_price":15,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-20-028421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654055/000089924320028421/doc4.xml","form_type":"4"}},{"id":3118094,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-08T21:36:45.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":13250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 5, 2021, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":13250,"derivative":{"exercise_price":5.29,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":13250},"source":{"system":"sec-edgar","filing":"0001209191-20-035038","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919120035038/doc4.xml","form_type":"4"}},{"id":3369543,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-15T21:22:06.000Z","date":"2019-11-13","kind":"grant","acquired":true,"shares":7437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on November 13, 2020, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":7437,"derivative":{"exercise_price":2.43,"expiration_date":"2029-11-12","underlying":"Common Stock","underlying_shares":7437},"source":{"system":"sec-edgar","filing":"0001209191-19-056735","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919119056735/doc4.xml","form_type":"4"}},{"id":3450518,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-01T20:58:41.000Z","date":"2019-06-10","kind":"grant","acquired":true,"shares":5813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Amended Form 4 is being filed to correct inaccuracies with respect to the transaction date and exercise price of the stock options and reported in Table II of the Form 4 filed on June 10, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in full on June 10, 2020, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":5813,"derivative":{"exercise_price":1.65,"expiration_date":"2029-06-09","underlying":"Common Stock","underlying_shares":5813},"source":{"system":"sec-edgar","filing":"0001209191-19-044045","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919119044045/doc4a.xml","form_type":"4/A","original_submission_date":"2019-06-10"}},{"id":3495269,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-10T20:19:57.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":5813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 7, 2020, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":5813,"derivative":{"exercise_price":1.6,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":5813},"source":{"system":"sec-edgar","filing":"0001209191-19-035784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919119035784/doc4.xml","form_type":"4"}},{"id":3625508,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-01T01:15:19.000Z","date":"2019-02-26","kind":"purchase","acquired":true,"shares":10000,"price":2.021,"value":20210.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.995 to 2.08 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-19-014804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919119014804/doc4.xml","form_type":"4"}},{"id":3841287,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-17T01:24:08.000Z","date":"2018-08-14","kind":"purchase","acquired":true,"shares":10000,"price":6.23,"value":62300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.005 to $6.5467 inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc., any security holder of Ovid Therapeutics Inc., or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-18-047230","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919118047230/doc4.xml","form_type":"4"}},{"id":3899498,"issuer":{"id":5411,"kind":"organization","name":"Ovid Therapeutics Inc."},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T21:40:25.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":5813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on June 7, 2019, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":5813,"derivative":{"exercise_price":8.12,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":5813},"source":{"system":"sec-edgar","filing":"0001209191-18-036747","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1636651/000120919118036747/doc4.xml","form_type":"4"}},{"id":3901443,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-07T18:56:33.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests with respect to 1/12th of the shares subject thereto on each monthly anniversary of the grant date, which vesting will accelerate in full on the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date."}],"balance_after":15000,"derivative":{"exercise_price":12.07,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-18-027772","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301501/000114036118027772/doc1.xml","form_type":"4"}},{"id":4257651,"issuer":{"id":158957,"kind":"organization","name":"Achaogen, Inc.","symbol":"AKAO"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-13T19:20:26.000Z","date":"2017-07-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 36 successive, equal monthly installments on each monthly anniversary of July 11, 2017, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":22.93,"expiration_date":"2027-07-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-17-027846","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1301501/000114036117027846/doc1.xml","form_type":"4"}},{"id":4574956,"issuer":{"id":181526,"kind":"organization","name":"Vitae Pharmaceuticals, Inc","symbol":"VTAE"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-25T16:32:31.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":11.38,"value":113800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 13, 2016, by and among the Issuer, Allergan Holdco US, Inc. and Augusta Merger Sub, Inc., each outstanding option to purchase shares of the Issuer's common stock, whether or not exercisable or vested, was cancelled and the holder thereof became entitled to receive an amount in cash determined by multiplying (A) the excess, if any, of $21.00 over the exercise price per share of the common stock underlying such stock option by (B) the number of shares of common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in four equal quarterly installments following May 26, 2016, was cancelled and the Reporting Person became entitled to receive an amount in cash per the terms of the Merger Agreement, as described in footnote (1) above."}],"balance_after":0,"derivative":{"exercise_price":9.62,"expiration_date":"2026-05-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-16-151942","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157602/000110465916151942/a4.xml","form_type":"4"}},{"id":4574955,"issuer":{"id":181526,"kind":"organization","name":"Vitae Pharmaceuticals, Inc","symbol":"VTAE"},"owners":[{"id":63872,"kind":"person","name":"Bernstein Karen","position":1,"cik":"0001654055","reported_name":"Bernstein Karen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-10-25T16:32:31.000Z","date":"2016-10-25","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":9.99,"value":199800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\"), dated September 13, 2016, by and among the Issuer, Allergan Holdco US, Inc. and Augusta Merger Sub, Inc., each outstanding option to purchase shares of the Issuer's common stock, whether or not exercisable or vested, was cancelled and the holder thereof became entitled to receive an amount in cash determined by multiplying (A) the excess, if any, of $21.00 over the exercise price per share of the common stock underlying such stock option by (B) the number of shares of common stock subject to such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting in equal quarterly installments for three years following September 30, 2015, was cancelled and the Reporting Person became entitled to receive an amount in cash per the terms of the Merger Agreement, as described in footnote (1) above."}],"balance_after":0,"derivative":{"exercise_price":11.01,"expiration_date":"2026-09-29","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-16-151942","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157602/000110465916151942/a4.xml","form_type":"4"}}]}